Loading Events

Identifying driver mutations of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in the blood

CHIP is characterized by the presence of a leukemia-associated mutation in the blood, at a VAF of at least 2%, in the absence of abnormal blood counts or blood cancer. The condition increases risk for morbidity and mortality, and can act as an important warning that disease may be on the horizon. In this talk, we will discuss how to accurately identify CHIP in blood samples and avoid common pitfalls that can lead to misclassifications.


Tara is a Human Genetics Candidate at Vanderbilt University in Nashville, Tennessee, USA. Under the primary mentorship of Dr. Alexander Bick, MD, PhD, her thesis work aims to understand progression rate of Clonal Hematopoiesis of Indeterminate Potential (CHIP). Broadly, she is interested in the genetics of complex disease, genetic modifications, and gene-by-environment interactions. 


This event will be held online via Zoom. Registrations essential.



Share This Story, Choose Your Platform!